Hepatic microsomal enzymes play an important role in thyroid hormone homeostasis. Glucuronidation of thyroxine is the rate limiting step in the biliary excretion of thyroxine in the rat; the monodeiodinases are important in the conversion of T4 to T3 and reverse T3 and subsequent deiodinations. Phenobarbital is known to affect thyroid function in rats due to an alteration of hormone disposition. We have further characterized these effects and have demonstrated that phenobarbital increases the biliary excretion of thyroxine glucuronide primarily as a result of an induction of hepatic thyroxine glucuronyltransferase. Studies on the mode of action for phenobarbital promotion of thyroid follicular neoplasia were conducted using an initiation-promotion model established by Hiasa et al (35). In this model, we demonstrated that supplemental administration of thyroxine blocked the promoting effect of phenobarbital and furthermore, using various dosages of thyroxine, we observed that the tumor promoting effect of phenobarbital was directly proportional to the level of plasma TSH. The results of these studies support the hypothesis that the the tumor promoting effect of phenobarbital in the thyroid gland is mediated via increased secretion of pituitary TSH as a compensatory response to the known effects of phenobarbital on peripheral thyroid hormone disposition. Since a number of microsomal enzyme inducing agents have increased the incidence of thyroid follicular neoplasia in rat carcinogenicity studies, thyroid function should be assessed and a secondary mechanism of hormone imbalance should be considered in the interpretation of the significance of these findings in rodents.
1. Axelrad AA and Leblond CP (1955). Induction of thyroid tumors in rats by a low iodine diet.Cancer8: 339–367.
2.
2. Bastomsky CH (1973). The biliary excretion of thyroxine and its glucuronic acid conjugate in normal and Gunn rats.Endocrinology92: 35–40.
3.
3. Bastomsky CH (1974). Effects of a polychlorinated biphenyl mixture (Arochlor 1254) and DDT on biliary thyroxine excretion in rats.Endocrinology95: 1150–1155.
4.
4. Bastomsky CH (1977). Enhanced thyroxine metabolism and high uptake goiters in rats after a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin.Endocrinology101: 292–296.
5.
5. Bastomsky CH and Murthy PVN (1976). Enhanced in vitro hepatic glucuronidation of thyroxine in rats following cutaneous application or ingestion of polychlorinated biphenyls.Can. J. Physiol. Pharmacol.54: 23–26.
6.
6. Bastomsky CH and Papapetrou PD (1973). The effect of methylcholanthrene on biliary thyroxine excretion in normal and Gunn rats.J. Endocrinol.56: 267–273.
7.
7. Bernstein G, Artz SA, Hasen J, and Oppenheimer JH (1968). Hepatic accumulation of 125I-thyroxine in the rat: Augmentation by phenobarbital and chlordane.Endocrinology82: 406–409.
8.
8. Bielschowsky F (1944). Tumors of the thyroid produced by 2-acetyl-amino-fluorene and allyl-thiourea.Br. J. Exp. Pathol.25: 90–95.
9.
9. Bielschowsky F (1953). Chronic iodine deficiency as cause of neoplasia in thyroid and pituitary of aged rats.Br. J. Cancer7: 203–213.
10.
10. Bolt HM, Bolt M, and Kappus H (1977). Interaction of Rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man.Acta Endocrinol.85: 189–197.
11.
11. Cavalieri RR, Gravin LA, Wallace A, Hammond ME, and Cruse K (1979). Serum thyroxine, free T4, triiodothyronine and reverse-T3 in diphenylhydantoin-treated patients.Metabolism28: 1161–1165.
12.
12. Cavalieri RR, Sung LC, and Becker CE (1973). Effects of phenobarbital on thyroxine and triiodothyronine kinetics in Graves’ Disease.J. Clin. Endocrin. Metab.37: 308–316.
13.
13. Chin W and Schussler GC (1968). Decreased serum free thyroxine concentration in patients treated with diphenylhydantoin.J. Clin. Endocrin. Metab.28: 181–186.
14.
14. Clemmesen J, Fuglsang-Fredriksen V, and Plum CM (1974). Are anticonvulsants oncogenic?Lancetii: 705–707.
15.
15. Clemmesen J and Hjalgrim-Jensen S (1978). Is phenobarbital carcinogenic? A follow-up of 8078 epileptics.Ecotoxicol. Environ. Safety1: 457–470.
16.
16. Clemmesen J and Hjalgrim-Jensen S (1981). Does phenobarbital cause intracranial tumors? A follow-up through 35 years.Ecotoxicol. Environ. Safety5: 255–260.
17.
17. Collins WT Jr and Capen CC (1980). Biliary excretion of 125I-thyroxine and fine structural alterations in the thyroid glands of Gunn rats fed polychlorinated biphenyls (PCB).Lab. Invest.43: 158–164.
18.
18. Collins WT Jr, Capen CC, Kasza L, Carter C, and Daily RE (1977). Effect of polychlorinated biphenyl (PCB) on the thyroid gland of rats.Am. J. Pathol.89: 119–136.
20. Cox AJ, Wilson RH, and DeEds F (1947). The carcinogenic activity of 2-acetylaminofluorene: Characteristics of the lesions in albino rats.Cancer Res.7: 647–657.
21.
21. Diwan BA, Palmer AE, Ohshima M, and Rice JM (1985a). N-nitroso-N-methylurea initiation in multiple tissues for organ-specific tumor promotion in rats by phenobarbital.J. Natl. Cancer Inst.75: 1099–1105.
22.
22. Diwan BA, Rice JM, Ohshima M, Ward JM, and Dove LF (1985b). Comparative tumor-promoting activities of phenobarbital, amobarbital, barbital sodium and barbituic acid on livers and other organs of male F344/NCr rats following initiation with N-nitrosodiethylamine.J. Natl. Cancer Inst.74: 509–515.
23.
23. Doniach I (1970). Aetological consideration of thyroid carcinoma. In: Tumors of the Thyroid Gland, Vol. 6, D Smithers (ed). E. & S. Livingstone, Edinburgh and London, pp. 55–72.
24.
24. EPA (1986). Guidelines for carcinogen risk assessment. Part II Environmental protection agency.Federal Register51: 33992–34003.
25.
25. Esmarch O (1942). Deposition of methylcholanthrene in some organs of the rat.Acta Path. Microbiol. Scand.19: 79–99.
26.
26. Furth J (1954). Morphologic changes associated with thyrotrophin secreting pituitary tumors.Am. J. Pathol.30: 421–463.
27.
27. Furth J (1959). A meeting of ways in cancer research: Thoughts on the evolution and nature of neoplasms.Cancer Res.19: 241–258.
28.
28. Furth J (1968). Pituitary Cybernetics and Neoplasia. The Harvey Lectures.Academic Press, New York/London, pp. 47–71.
29.
29. Goldstein JA and Taurog A (1968). Enhanced biliary excretion of thyroxine glucuronide in rats pretreated with benzpyrene.Biochem. Pharmacol.17: 1049–1065.
30.
30. Gnatyshak AI (1957). Experimental thyroid tumors and accompanying changes in some endocrine glands.Vop. Onkol.3: 659–665.
31.
31. Hansen JM, Skovsted L, Lauridsen UB, Kirkegaard C, and Siersbaek-Nielsen K (1974). The effect of diphenylhydantoin on thyroid function.J. Clin. Endocrinol. Metab.39: 785–789.
32.
32. Henry EC and Gasciewicz TA (1987). Changes in thyroid hormones and thyroxine glucuronidation in hamsters compared with rats following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.Toxicol. Appl. Pharmacol.89: 165–174.
33.
33. Hiasa Y, Kitahori Y, Konishi N, Enoki N, and Fujita T (1984). Promoting effect of phenobarbital on N-bis(2-hydroxypropyl)nitrosamine thyroid tumorigenesis in rats. Effect of varying duration of exposure to phenobarbital.IARC Sci. Publ.56: 77–82.
34.
34. Hiasa Y, Kitahori V, Konishi N, Shimoyana T, and Lin JC (1985). Sex differential and dose dependence of phenobarbital-promoting activity in N-bis(2-hydroxypropyl) nitrosamine-initiated thyroid tumorigenesis in rats.Cancer Res.45: 4087–4090.
35.
35. Hiasa Y, Kitahori V, Oshima M, Fujita T, Yuasa T, Konishi N, and Miyashiro A (1982a). Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine.Carcinogenesis3: 1187–1190.
36.
36. Hiasa Y, Ohshima M, Kitahori Y, Yuasa T, Fujita T, and Iwata C (1982b). Promoting effects of 3-amino-1,2,4-triazole on the development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine.Carcinogenesis3: 381–384.
37.
37. International Agency for Research on Cancer (1974). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man: Some Anti-thyroid and Related Substances, Nitrofurans and Industrial Chemicals, Vol. 7. IARC, Lyon, France, pp. 23–24.
38.
38. International Agency for Research on Cancer (1987). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs, Vols. 1–42, Suppl. 7. IARC, Lyon, France, pp. 17–34.
39.
39. Isler H, Leblond CP, and Axelrad AA (1958). Influence of age and of iodine intake on the production of thyroid tumors in the rat.J. Natl. Cancer Inst.21: 1065–1081.
40.
40. Japundzic MM (1969). The goitrogenic effect of phenobarbital-Na on the rat thyroid.Acta Anat.74: 88–96.
41.
41. Kennedy TH and Purves HD (1941). Studies on experimental goitre. I. The effect of brassica seed diets on rats.Br. J. Exp. Pathol.22: 241–244.
42.
42. Larsen PR, Atkinson AJ, Wellman HN, and Goldsmith RE (1970). The effect of diphenylhydantoin on thyroxine metabolism in man.J. Clin. Invest.49: 1266–1279.
43.
43. Leblond CP, Isler H, and Axelrad A (1957). Induction of thyroid tumors by a low iodine diet.Can. Cancer Conf.2: 248–266.
44.
44. Levin W, Welch RM, and Conney AH (1974). Increased liver microsomal androgen metabolism by phenobarbital: Correlation with decreased androgen action on the seminal vesicles of the rat.J. Pharmacol. Exp. Ther.188: 287–292.
45.
45. Liewendahl K and Majuri H (1976). Thyroxine, triiodothyronine and thyrotropin in serum during long-term diphenylhydantoin therapy.Scand. J. Clin. Lab. Invest.36: 141–144.
46.
46. McClain RM, Levin A, Posch R, and Downing JC (1989). The effect of phenobarbital on the metabolism and excretion of thyroxine in rats.Toxicol. Appl. Pharmacol.992: 216–228.
47.
47. McClain RM, Posch RC, Bosakowski T, and Armstrong JM (1988). Studies on the mode of action for thyroid gland tumor promotion in rats by phenobarbital.Toxicol. Appl. Pharmacol.94: 254–265.
48.
48. Morris HP (1955). The experimental development and metabolism of thyroid gland tumors.Adv. Cancer Res.3: 51–115.
49.
49. Myant NB (1958). The biliary excretion of thyroid hormone.Lect. Scient. Basis Med.6: 313–332.
50.
50. Napalkov NP (1976). Tumors of the thyroid gland. In: Pathology of Tumors in Laboratory Animals, Vol. 1, Part 2, Tumors of the Rat, VS Turusov (ed). IARC Scientific Publication No. 6, Lyon, France.
51.
51. OSTP (1985). Office of science and technology policy report on chemical carcinogens.Federal Register50: 10372–10442.
52.
52. Ohnhaus EE and Studer H (1983). A link between liver microsomal enzyme activity and thyroid hormone metabolism in man.Br. J. Clin. Pharmacol.15: 71–76.
53.
53. Oppenheimer JH, Bernstein G, and Surks MI (1968). Increased thyroxine turnover and thyroidal function after stimulation of hepatocellular binding of thyroxine by phenobarbital.J. Clin. Invest.47: 1399–1406.
54.
54. Paynter OE, Burin GJ, Jaeger RB, and Gregorio CA (1988). Goitrogens and thyroid follicular cell neoplasia: Evidence for a threshold process.Regulatory Tox. and Pharmacol.8: 102–119.
55.
55. Peraino C, Fry RJM, and Staffeldt E (1971). Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene.Cancer Res.31: 1506–1512.
56.
56. Pliss GB (1959) The blastomogenic action of dichlorobenzidene. Vop. Onkol.5: 524–533.
58. Schulte-Hermann R (1974). Induction of liver growth by xenobiotic compounds and other stimuli. In: Critical Reviews in Toxicology, 1st ed., Vol. 3, L Goldberg (ed). CRC Press, Cleveland, pp. 97–158.
59.
59. Schulte-Hermann R, Parzefall W, and Bursch W (1987). Role of stimulation of liver growth by chemicals in hepatocarcinogenesis. In: Banbury Report No. 25: Nongenotoxic Mechanisms in Carcinogenesis, BE Butterworth and TJ Slaga (eds). Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 91–106.
60.
60. Schwartz HL, Kozyreff V, Surks MI, and Oppenheimer JH (1969). Increased deiodination of 1-thyroxine and 1-triiodothyronine by liver microsomes from rats treated with phenobarbital.Nature221: 1262–1263.
61.
61. Swarm RL, Roberts GKS, Levy AC, and Hines LR (1973). Observations on the thyroid gland in rats following the administration of sulfamethoxazole and trimethoprim.Toxicol. Appl. Pharmacol.24: 351–363.
62.
62. Taurog A (1955). Conjugation and excretion of thyroid hormone.Brookhaven Symp. Biol.7: 111–136.
63.
63. Tsuda H, Fukushima S, Imaida K, Kurata Y, and Ito N (1983). Organ-specific promoting effect of phenobarbital and saccharin in induction of thyroid, liver, and urinary bladder tumors in rats after initiation with N-nitrosomethylurea.Cancer Res.43: 3292–3296.
64.
64. Werk EE Jr, Thrasher K, Sholiton LJ, Olinger C, and Choi Y (1971). Cortisol production in epileptic patients treated with diphenylhydantoin.Clin. Pharmacol. Ther.12: 698–703.
65.
65. Williams GM and Weisburger JH (1985). Carcinogenicity testing of drugs.Prog. Drug Res.29: 155–213.
